Suppr超能文献

硫唑嘌呤治疗慢性顽固性麻风结节性红斑:一例报告

Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case Report.

作者信息

Jitendra Singh Shailendra Vikram, Bachaspatimayum Romita, Devi A Subhalakshmi, Rita S

机构信息

Postgraduate Student, Department of Pharmacology, Regional Institute of Medical Sciences, Imphal, Manipur, India.

Assistant Professor, Department of Dermatology, Venereology and Leprosy, Regional Institute of Medical Sciences, Imphal, Manipur, India.

出版信息

J Clin Diagn Res. 2017 Aug;11(8):FD01-FD02. doi: 10.7860/JCDR/2017/26536.10499. Epub 2017 Aug 1.

Abstract

Erythema Nodosum Leprosum (ENL) may have a chronic course which may be recalcitrant to treatment. Preferred treatment modalities are systemic corticosteroids and thalidomide. Azathioprine, methotrexate and cyclosporine are immunosuppressants which may also be used as a steroid sparing agent. We report the case of a 48-year-old male diagnosed as lepromatous leprosy that developed ENL after four months of Multibacillary Multi-Drug Therapy (MB-MDT). He was treated with oral prednisolone (1 mg/kg/day) which was gradually tapered upto a dose of 7.5 mg/day. He developed recurrences on and off once the dose reached the said level and this continued for three years. Oral clofazamine (300 mg/day x 6 months; then 100 mg/day x 6 months) was also added in the second year. Thalidomide (200 mg/day) was also given but withdrawn due to adverse effect after 10 days. Azathioprine was started at a dose of 100 mg/day following which there was resolution of symptoms by one week and no recurrences by 10 weeks; it was given for eight months after which the dose was tapered to 50 mg/day for another four months. Complete withdrawal of oral prednisolone after gradual tapering was possible by 12 months of azathioprine therapy. The patient is still on regular follow-up with no recurrences so far till the last check-up.

摘要

结节性红斑麻风(ENL)可能病程呈慢性,且治疗可能效果不佳。首选治疗方式为全身使用皮质类固醇和沙利度胺。硫唑嘌呤、甲氨蝶呤和环孢素是免疫抑制剂,也可用作类固醇节约剂。我们报告一例48岁男性病例,该患者被诊断为瘤型麻风,在接受多菌型联合化疗(MB-MDT)四个月后出现ENL。他接受口服泼尼松龙治疗(1毫克/千克/天),剂量逐渐减至7.5毫克/天。一旦剂量达到上述水平,病情就会反复,这种情况持续了三年。第二年还加用了口服氯法齐明(300毫克/天,共6个月;然后100毫克/天,共6个月)。也给予了沙利度胺(200毫克/天),但10天后因不良反应停药。开始使用硫唑嘌呤,剂量为100毫克/天,一周后症状缓解,10周后无复发;用药8个月后,剂量减至50毫克/天,再用4个月。硫唑嘌呤治疗12个月后,可逐渐减量并完全停用口服泼尼松龙。该患者仍在定期随访,直至最后一次检查,目前尚无复发。

相似文献

4
Therapeutic Dilemma of Refractory Erythema Nodosum Leprosum.难治性麻风结节性红斑的治疗困境
Am J Trop Med Hyg. 2017 Jun;96(6):1362-1364. doi: 10.4269/ajtmh.16-0118.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验